These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8649040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N.
    Cancer Res; 1991 Mar 01; 51(5):1472-7. PubMed ID: 1997185
    [Abstract] [Full Text] [Related]

  • 4. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
    Kurihara N, Kubota T, Hoshiya Y, Otani Y, Watanabe M, Kumai K, Kitajima M.
    J Surg Oncol; 1996 Feb 01; 61(2):138-42. PubMed ID: 8606546
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
    Terashima M, Ikeda K, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Irinoda T, Nakaya T, Oyama K, Saito K.
    Gan To Kagaku Ryoho; 1997 Sep 01; 24(12):1859-62. PubMed ID: 9382551
    [Abstract] [Full Text] [Related]

  • 6. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L.
    Anticancer Res; 1995 Sep 01; 15(6B):2541-7. PubMed ID: 8669820
    [Abstract] [Full Text] [Related]

  • 7. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N, Kumai K, Kubota T, Furukawa T, Yamamoto T, Shimada A, Shibata S, Saikawa Y, Ogawa S, Murayama Y.
    Gan To Kagaku Ryoho; 1993 Aug 01; 20(11):1645-8. PubMed ID: 8373238
    [Abstract] [Full Text] [Related]

  • 8. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W, Braess J, Kotschofsky M, Samel S, Becker H, Hiddemann W, Schleyer E.
    Anticancer Res; 2002 Aug 01; 22(5):3099-102. PubMed ID: 12530050
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.
    Forastiere AA, Belliveau JF, Goren MP, Vogel WC, Posner MR, O'Leary GP.
    Cancer Res; 1988 Jul 01; 48(13):3869-74. PubMed ID: 3378222
    [Abstract] [Full Text] [Related]

  • 10. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S, Egorin M, Aisner J, Bachur N, Wiernik PH.
    Cancer Clin Trials; 1980 Jul 01; 3(1):23-7. PubMed ID: 7190082
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion.
    Lokich JJ.
    Cancer Treat Rep; 1980 Jul 01; 64(8-9):905-8. PubMed ID: 6256073
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacokinetic analysis of low-dose intra-peritoneal cis-platinum administration].
    Terashima M, Ikeda K, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Irinoda T, Nakaya T, Oyama K, Saito K.
    Gan To Kagaku Ryoho; 1998 Jul 01; 25(9):1433-5. PubMed ID: 9703846
    [Abstract] [Full Text] [Related]

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 01; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study.
    Tsuji A, Shima Y, Morita S, Uchida M, Okamoto K, Morita M, Horimi T, Shirasaka T.
    Anticancer Res; 2008 Nov 01; 28(2B):1433-8. PubMed ID: 18505092
    [Abstract] [Full Text] [Related]

  • 15. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
    Taguchi T, Wakui A, Nabeya K, Kurihara M, Isono K, Kakegawa T, Ota K.
    Gan To Kagaku Ryoho; 1992 Apr 01; 19(4):483-8. PubMed ID: 1558398
    [Abstract] [Full Text] [Related]

  • 16. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM, Dijkman R, Begg AC, Dubbelman R, Floot BG, Hart AA, den Engelse L.
    Cancer Res; 1988 Oct 01; 48(19):5597-603. PubMed ID: 3046743
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T, Uno T, Yasui-Furukori N, Takahata T, Shimizu M, Sugawara K, Tateishi T.
    Cancer Chemother Pharmacol; 2007 Apr 01; 59(5):575-80. PubMed ID: 16912889
    [Abstract] [Full Text] [Related]

  • 18. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G.
    Laryngoscope; 2004 Sep 01; 114(9):1660-7. PubMed ID: 15475801
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
    Stathopoulos GP, Boulikas T, Vougiouka M, Deliconstantinos G, Rigatos S, Darli E, Viliotou V, Stathopoulos JG.
    Oncol Rep; 2005 Apr 01; 13(4):589-95. PubMed ID: 15756428
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME, Apostoli P, Benoni G, Bonetti A, Griso C, Leone R.
    Drugs Exp Clin Res; 1987 Apr 01; 13(6):367-72. PubMed ID: 3652926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.